NL
NL · NL · NL-c71c26aa7742
Rybrevant 2240 mg, oplossing voor injectie
ATC L01FX18
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerJanssen-Cilag International NV
CountryNL (NL)
ATC codeL01FX18
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/21/1594
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/rybrevant-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Amivantamab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp136730",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"DINATRIUMEDETAAT 2-WATER",
"HYALURONIDASE PH20, HUMAAN, RECOMBINANT",
"METHIONINE, (L-)",
"NATRIUMACETAAT 3-WATER (E 262)",
"POLYSORBAAT 80 (E 433)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"AMIVANTAMAB"
],
"leaflet_url": null,
"authorised_at": "2025/04/07",
"procedure_number": "EMEA/H/C/005454",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1594",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code L01FX18.
- NORybrevantJanssen-Cilag International N.V.
- PLRybrevantJanssen-Cilag International N.V.
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- ISRybrevantJanssen-Cilag International NV*
- PLRybrevantJanssen-Cilag International N.V.
Access this data programmatically
Query Rybrevant 2240 mg, oplossing voor injectie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.